AIA Group Ltd Acquires 34,502 Shares of Corteva, Inc. $CTVA

AIA Group Ltd increased its holdings in Corteva, Inc. (NYSE:CTVAFree Report) by 41.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 118,169 shares of the company’s stock after buying an additional 34,502 shares during the quarter. AIA Group Ltd’s holdings in Corteva were worth $7,992,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CTVA. Brighton Jones LLC grew its position in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP raised its holdings in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the period. Foundations Investment Advisors LLC raised its holdings in Corteva by 6.3% in the 2nd quarter. Foundations Investment Advisors LLC now owns 5,165 shares of the company’s stock worth $385,000 after purchasing an additional 305 shares during the period. Meridian Wealth Management LLC purchased a new position in Corteva during the second quarter valued at $205,000. Finally, Cetera Investment Advisers grew its holdings in Corteva by 2.9% during the second quarter. Cetera Investment Advisers now owns 132,333 shares of the company’s stock valued at $9,863,000 after purchasing an additional 3,748 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Trading Down 0.8%

Shares of CTVA opened at $79.38 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.90. The company has a 50 day simple moving average of $74.77 and a two-hundred day simple moving average of $69.32. The firm has a market cap of $53.39 billion, a P/E ratio of 50.24, a price-to-earnings-growth ratio of 2.74 and a beta of 0.72.

Corteva (NYSE:CTVAGet Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the prior year, the business earned $0.32 earnings per share. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s payout ratio is currently 45.57%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $88.00 price objective on shares of Corteva in a research note on Thursday, February 5th. Citigroup boosted their price objective on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Argus upgraded shares of Corteva to a “strong-buy” rating in a research note on Friday, January 16th. Finally, Wells Fargo & Company lifted their price target on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.90.

View Our Latest Stock Report on Corteva

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.14% of the company’s stock.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.